EUVIMEDEUVIMED entdecken
Open Access

Synthesis of Potent Vanin‐1 Inhibitors Labelled With Carbon‐14 and Deuterium

Bachir Latli iD, Matt Hrapchak, Ling Wu, Lalith Samankumara, Jaehee Lee iD, Bo Qu iD

Journal of Labelled Compounds and Radiopharmaceuticals · 2026-07 · 69 (9)

DOI: 10.1002/jlcr.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 09.07.2026. Verfasst von Bachir Latli und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Radiosynthesis Laboratory, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. Hauptthemen laut MEDLINE: Carbon Radioisotopes, Deuterium, Enzyme Inhibitors, N-Glycosyl Hydrolases. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vanin‐1 is an enzyme highly expressed in the kidneys, liver, and small intestines. Inhibition of this enzyme has been postulated as a novel approach in the treatment of several inflammatory diseases. BI 764122 , BI 1585773 , and BI 1595043 are very potent inhibitors of this enzyme. These three analogs share the same ( S )‐ N ‐(nicotinoyl)pyrrolidin‐3‐yl)‐ N ‐methyl acetamide moiety. The preparation of these analogs labelled with carbon‐14 was accomplished via carbon‐14 carboxylation with carbon dioxide of corresponding aryl halides, followed by amide bond formation with ( S )‐ N ‐(methyl)‐ N‐ (pyrrolidin‐3‐yl)acetamide. For metabolic considerations, the radioactive carbon was also incorporated in a cyclopropyl in [ 14 C ] ‐BI 764122 synthesis. The deuterium labelling of these three compounds was completed using the common moiety ( S )‐ N ‐(methyl‐ d 3 )‐ N ‐(pyrrolidin‐3‐yl)acetamide‐ d 3 , which was prepared in three steps and then coupled to the corresponding aryl acids via amide bond.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon RadioisotopesDeuteriumEnzyme InhibitorsN-Glycosyl HydrolasesIsotope LabelingChemistry Techniques, Synthetic

Stichwörter der Autor:innen

BI 1585773BI 1595043BI 764122carbon‐14deuteriumvanin‐1

Substanzen

Carbon RadioisotopesDeuteriumEnzyme InhibitorsCarbon-14N-Glycosyl Hydrolases

Autor:innen und Institutionen

  • The Radiosynthesis Laboratory, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.

ORCID-Profile: Bachir Latli, Jaehee Lee, Bo Qu

Zitieren

APA

Latli, B., Hrapchak, M., Wu, L., Samankumara, L., Lee, J., & Qu, B. (2026). Synthesis of Potent Vanin‐1 Inhibitors Labelled With Carbon‐14 and Deuterium. Journal of Labelled Compounds and Radiopharmaceuticals, 69(9). https://doi.org/10.1002/jlcr.70033

Vancouver

Latli B, Hrapchak M, Wu L, Samankumara L, Lee J, Qu B. Synthesis of Potent Vanin‐1 Inhibitors Labelled With Carbon‐14 and Deuterium. Journal of Labelled Compounds and Radiopharmaceuticals. 2026;69(9). doi:10.1002/jlcr.70033

BibTeX
@article{Latli2026,
  author = {Latli, Bachir and Hrapchak, Matt and Wu, Ling and Samankumara, Lalith and Lee, Jaehee and Qu, Bo},
  title = {Synthesis of Potent Vanin‐1 Inhibitors Labelled With Carbon‐14 and Deuterium},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2026},
  volume = {69},
  number = {9},
  doi = {10.1002/jlcr.70033}
}
Kostenlos starten →